The launch of the vaccine named, Vanguard CIV H3N2/H3N8 Vaccine, was announced in December 2017 by Zoetis. This was the most recent vaccine in the list of the company’s canine influenza vaccine portfolio. Such initiatives taken by companies towards the launch of vaccines to protect animals from various diseases is promoting the growth of the global veterinary vaccines market, predicts Fortune Business Insights in their new report.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/veterinary-animal-vaccines-market-101532
According to the report, the market is anticipated to rise from a value of USD 9.75 Billion in 2018 to USD 16.01 Billion by 2026. The forecast period is set from 2019 to 2026 and the market is expected to rise at a CAGR of 6.4%.
The global veterinary vaccines market is segmented on the basis of product, animal, and route of administration, distribution channel, and geography. Among these, the parental animal vaccines segment will earn the highest revenue in the forecast duration with respect to route of administration. This is owing to the fact that parental animal vaccines are among the most traditional and common forms of vaccinations. On the other side, the companion animal segment is prognosticated to grow at rapid CAGR in the forecast period, with respect to animal. This is attributable to the rise in number of pet ownership on a worldwide basis.
Increasing Awareness About Diseases Contracted from Animals by Humans to Fuel Demand for Veterinary Vaccines
The rise in awareness about importance of veterinary healthcare is a major factor boosting the global veterinary vaccines market. The increase in the number of pet owners worldwide is also anticipated to help the market gain traction. Increasing investments in research and development by manufacturers for development of novel veterinary vaccines are also anticipated to promote the global veterinary vaccines market growth during the forecast period. Moreover, the prevalence of diseases that can pass on to humans from animals such as trichinella spiralis, rabies, and others may also help in the veterinary vaccines market growth.
